Wave Life Sciences Ltd.

WVE· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$4.35-2.03%

2026-09-18

Financials

Valuation Metrics

Wave Life Sciences Ltd.'s Market Cap is $837M. At end of 2025 it was $3.06B. Ranked #2550 of 3,121 in US market (top 82%), #1064 of 1,463 on NASDAQ (top 73%), #197 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 74%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$837M	US#2,550/3,121 Sec#197/266
Revenue	$65M	US#2,753/3,121 Sec#140/266
Net Income	$-202M	US—/3,121 Sec—/266
Total Assets	$558M	US#2,729/3,121 Sec#151/266
Net Assets	$454M	US#2,295/3,121 Sec#118/266
Value
P/B	1.85x	US#1,158/3,121 Sec#43/266
P/S	12.80x	US#2,758/3,121 Sec#121/266
FCF Yield	-22.25%	US—/3,121 Sec—/266
Profitability
ROE	-44.64%	US#2,659/3,121 Sec#148/266
ROA	-36.26%	US#2,926/3,121 Sec#177/266
Op. Margin	-333.36%	US#2,793/3,121 Sec#146/266
Revenue Growth	-30.42%	US#2,719/3,121 Sec#158/266
Financial Health
Debt Ratio	23.11%	US#259/3,121 Sec#88/266
Total Debt	$44M	US#2,637/3,121 Sec#159/266
FCF	$-186M	US#2,764/3,121 Sec#201/266
Cash	$368M	US#1,265/3,121 Sec#70/266
Current Ratio	9.99x	US#257/3,121 Sec#80/266
Performance
1Y Return	-37.50%	US#2,715/3,121 Sec#231/266
1M Return	-19.74%	US#2,856/3,121 Sec#223/266
From 52W High	-79.98%	US#3,079/3,121 Sec#260/266
1Y MDD	-79.59%	US#3,061/3,121 Sec#254/266
Trading
Volume	3,408,605 shares	US#787/3,121 Sec#81/266
Trading Value	$15M	US#2,384/3,121 Sec#196/266
Per Share
EPS	$-1.05	US—/3,121 Sec—/266
BPS	$2.36	US#2,550/3,121 Sec#172/266